Document is current
Any future updates will be listed below
-
Authors
Qin, Mubing
Yu, Shiyuan
Lu, Xin
Gong, Chao
Song, Zengrui
Zhu, Huadong
Gao, Yanxia
Li, Yi
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04230447 at ClinicalTrials.govDocuments that mention this clinical trial
Reduced phosphatidylcholine and phosphatidylethanolamine levels correlate with inflammatory activation in sepsis-associated encephalopathy
https://doi.org/10.1186/s40001-025-03115-z
-
Funding
Funding for this research was provided by:
Special Research Fund for Central Universities, Peking Union Medical College (3332024120)
National Natural Science Foundation of China (82402543)
CAMS Innovation Fund for Medical Sciences (2021-1-I2M-020)
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-109)
- License Information
-
More Information
Article History
Received: 28 May 2025
Revised: 17 July 2025
Accepted: 23 August 2025
First Online: 31 August 2025
Declarations
:
: All procedures were followed as per the ethical standards of the Ethics Institutional Review Board of Peking Union Medical College Hospital (PUMCH) (serial number: ZS-2165).
: Not applicable.
: The authors declare no competing interests.
